Answer
Ponatinib is contraindicated in patients with hypersensitivity to the active substance or any excipient listed in section 6.1.
Sources for this answer
- Ponatinib Incyte 30 mg film-coated tabletsIncyte Biosciences UK Ltd · emc · SmPC §4.3 Contraindications · Version 5Document updated
Sources checked